The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.

Author

Candace Gwaltney

Candace Gwaltney is the science writer for the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

Showing results for Candace Gwaltney

Michelle Coté, PhD, at the Komen Tissue Bank

Q&A with Michele Coté, PhD

Michele Coté, PhD, is just getting started in her new role as the second director of the Susan G. Komen Tissue Bank at IU Simon Comprehensive Cancer Center. An internationally recognized molecular cancer epidemiologist and health disparities researcher, she began at IU on Sept. 1.

Candace Gwaltney | Sep 01, 2022

Pagano celebrates after making the $1 million shot.

Chuckstrong Backyard Huddle raises nearly $2.5 million for cancer research

In a night that brought together cancer survivors, researchers and philanthropists, the Chuckstrong Backyard Huddle raised nearly than $2.5 million July 29 for cancer research at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

Candace Gwaltney | Aug 02, 2021

Indiana Myeloma Registry tracks individual patient journeys, data in search of a cure

Hoosiers with multiple myeloma can provide important data to researchers at Indiana University Melvin and Bren Simon Comprehensive Cancer Center who are searching for a cure. The Indiana Myeloma Registry is seeking participants throughout Indiana.

Candace Gwaltney | Mar 25, 2021

Indiana-native researcher is the 2020 Vera Bradley Foundation Scholar

Candace Gwaltney | Aug 10, 2020

Patient case study provides insight to toxicity from chemotherapy used for breast, colon cancers

Candace Gwaltney | Aug 03, 2020

Named an IU Distinguished Professor, Roodman continues storied multiple myeloma research career

Progress in multiple myeloma research and improved outcomes for patients is the driving force for physician scientist G. David Roodman, M.D., Ph.D. Roodman started researching and treating multiple myeloma, a blood cancer of plasma cells within the bone marrow, in the early 1980s.

Candace Gwaltney | Jun 17, 2020